ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
83.92
+1.05 (1.27%)
At close: Oct 3, 2025, 4:00 PM EDT
83.92
0.00 (0.00%)
After-hours: Oct 3, 2025, 4:00 PM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$102,513
Profits / Employee
-$3,325,555
Market Cap
6.19B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 69 | 8 | 13.11% |
Dec 31, 2023 | 61 | 37 | 154.17% |
Dec 31, 2022 | 24 | 0 | - |
Dec 31, 2021 | 24 | -3 | -11.11% |
Dec 31, 2020 | 27 | 1 | 3.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ABVX News
- 4 days ago - Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting - GlobeNewsWire
- 10 days ago - Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting - GlobeNewsWire
- 21 days ago - Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - GlobeNewsWire
- 25 days ago - Abivax Presents First Half 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - How Hedge Funds Won Big on an Obscure Drugmaker - WSJ
- 5 weeks ago - 2 Logical Mid-Cap Biotech Buyout Targets - Seeking Alpha
- 2 months ago - Abivax Announces Closing of $747.5 Million Public Offering - GlobeNewsWire
- 2 months ago - Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) - GlobeNewsWire